FDA Device Intelligence
Home › MKG Consulting UG (haftungsbeschränkt) › Corowell COVID-19 Symptom Screening Test

Corowell COVID-19 Symptom Screening Test

MKG Consulting UG (haftungsbeschränkt) · Model 1 · UDI-DI 04260698980015

NRK
1
510(k) clearances
0
Adverse events
0
Recalls
7
Facilities

Description

The Corowell COVID-19 Symptom Screening Test is intended to objectively testing of the sense of smell. It enables the identification of subjects whose olfactory perception is deviating, restricted or newly got lost. The Corowell COVID-19 Symptom Screening Test is a device for home use. The Corowell COVID-19 Symptom Screening Test can be performed self-administered by the subject. The target population is adults over 18 years of age.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.